Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures

Neurosci Lett. 2002 May 3;323(3):191-4. doi: 10.1016/s0304-3940(02)00146-5.

Abstract

Premarin, which contains several equine estrogens, as well as estradiol (E2) as a minor component, is widely used for replacement therapy of estrogen deficits, but little is known of its direct actions on brain cells. In mixed glial cultures, apolipoprotein E (apoE) and glial fibrillary acidic protein (GFAP) are induced by estrogens. GFAP induction showed an inverted-U shape E2 dose response, with a maximum induction at 1 pM, whereas apoE mRNA induction was greatest at 100 pM. GFAP and ApoE mRNAs were induced by equine estrogens in the following order: E2=equilin>estrone>17 alpha-dihydroequilenin. However, the induction of apoE secretion by 17 alpha-dihydroequilenin was as effective as by the other estrogens. The greater response of apoE secretion than GFAP mRNA induction to 17 alpha-dihydroequilenin might be therapeutically important because of the glial scarring during brain lesions, in which GFAP induction has a major role in inhibiting neurite outgrowth, whereas apoE secretion supports neurite outgrowth.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apolipoproteins E / genetics*
  • Astrocytes / cytology
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • Brain / cytology
  • Brain / drug effects*
  • Brain / metabolism
  • Brain Injuries / drug therapy
  • Brain Injuries / metabolism
  • Brain Injuries / physiopathology
  • Cells, Cultured
  • Coculture Techniques
  • Dose-Response Relationship, Drug
  • Equilin / analogs & derivatives*
  • Equilin / pharmacology
  • Estradiol / pharmacology
  • Estrogens / metabolism
  • Estrogens / pharmacology*
  • Estrogens, Conjugated (USP) / pharmacology
  • Estrogens, Conjugated (USP) / therapeutic use
  • Estrone / pharmacology
  • Glial Fibrillary Acidic Protein / genetics*
  • Gliosis / drug therapy
  • Gliosis / physiopathology
  • Gliosis / prevention & control
  • Horses
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacology*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Up-Regulation / drug effects*
  • Up-Regulation / physiology

Substances

  • Apolipoproteins E
  • Estrogens
  • Estrogens, Conjugated (USP)
  • Glial Fibrillary Acidic Protein
  • Neuroprotective Agents
  • RNA, Messenger
  • Equilin
  • Estrone
  • Estradiol
  • dihydroequilin